|
시장보고서
상품코드
1991419
COPD 및 천식 치료 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global COPD and Asthma Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
COPD 및 천식용 의료기기 시장 규모는 2025년 472억 달러에서 2034년에는 713억 1,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 4.69%로 성장할 것으로 전망됩니다.
전 세계 COPD 및 천식 치료 기기 시장은 전 세계 호흡기질환의 유병률 증가에 따라 강력한 성장세를 보이고 있습니다. 흡입기, 분무기, 호흡 모니터링 기기 등의 기기는 만성 호흡기질환의 관리에 있어 매우 중요한 역할을 하고 있습니다. 대기오염의 악화, 흡연 습관 및 환경적 요인이 호흡기질환 진단을 받는 환자 수 증가에 기여하고 있습니다. 의료진은 환자 치료와 질병 관리를 개선하기 위해 첨단 호흡기 기기를 점점 더 많이 도입하고 있습니다.
시장 성장은 성인과 소아 모두에서 만성폐쇄성폐질환(COPD)과 천식의 부담이 증가함에 따라 주도되고 있습니다. 흡입 요법 기기의 기술적 진보로 약물전달 효율과 환자 편의성이 향상되었습니다. 환자들이 의료기관 밖에서도 효과적으로 증상을 관리할 수 있는 방법을 찾으면서 휴대가 간편하고 사용하기 쉬운 기기의 인기가 높아지고 있습니다. 헬스케어에 대한 인식 제고와 조기 진단 프로그램 보급도 호흡기 치료 기기의 채택 확대에 기여하고 있습니다.
헬스케어 혁신으로 호흡기 치료가 지속적으로 개선되면서 COPD 및 천식 치료 기기 시장의 향후 전망은 여전히 밝다고 할 수 있습니다. 스마트 흡입기와 디지털 모니터링 시스템은 보다 효과적인 질병 추적과 치료 순응도를 높일 수 있습니다. 원격의료와 원격 환자 모니터링의 확대는 환자 관리를 더욱 강화할 것입니다. 의료 시스템이 호흡기질환의 치료 성과 향상에 집중함에 따라 첨단 COPD 및 천식 치료 기기에 대한 수요가 증가할 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 COPD 및 천식 치료 기기 시장 : 제품별
제5장 세계의 COPD 및 천식 치료 기기 시장 : 적응증별
제6장 세계의 COPD 및 천식 치료 기기 시장 : 유통 채널별
제7장 세계의 COPD 및 천식 치료 기기 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.04.14The COPD and Asthma Devices Market size is expected to reach USD 71.31 Billion in 2034 from USD 47.20 Billion (2025) growing at a CAGR of 4.69% during 2026-2034.
The global COPD and asthma devices market has witnessed strong growth due to the increasing prevalence of respiratory diseases worldwide. Devices such as inhalers, nebulizers, and respiratory monitoring equipment play a crucial role in managing chronic respiratory conditions. Rising air pollution levels, smoking habits, and environmental factors have contributed to the growing number of individuals diagnosed with respiratory disorders. Healthcare providers are increasingly adopting advanced respiratory devices to improve patient treatment and disease management.
Market growth is driven by the rising burden of chronic obstructive pulmonary disease and asthma among both adults and children. Technological advancements in inhalation therapy devices have improved medication delivery and patient convenience. Portable and user-friendly devices are becoming more popular as patients seek effective ways to manage symptoms outside clinical settings. Increasing healthcare awareness and early diagnosis programs have also contributed to higher adoption of respiratory treatment devices.
The future outlook for the COPD and asthma devices market remains positive as healthcare innovation continues to improve respiratory care. Smart inhalers and digital monitoring systems may enable better disease tracking and treatment adherence. Expansion of telemedicine and remote patient monitoring could further enhance patient management. As healthcare systems focus on improving respiratory disease outcomes, demand for advanced COPD and asthma treatment devices is expected to rise.
MARKET SEGMENTATION
By Product
- Inhalers
- Nebulizers
By Indication
- Asthma
- COPD
By Distribution Channel
- Retail Pharmacies
- Hospitals
- Online Pharmacies
COMPANIES PROFILED
- GF Health Products Inc, Koninklijke Philips NV Philips, 3M Company, Boehringer Ingelheim International GmbH, PARI medical Holding GMBH, AstraZeneca PLC, Smiths Group Plc, Aerogen Inc, Baxter International Inc, GlaxoSmithKline Plc, Novartis AG
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL COPD AND ASTHMA DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Inhalers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Nebulizers Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL COPD AND ASTHMA DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Indication
- 5.2. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL COPD AND ASTHMA DEVICES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Distribution Channel
- 6.2. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL COPD AND ASTHMA DEVICES MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By Indication
- 7.2.3 By Distribution Channel
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By Indication
- 7.3.3 By Distribution Channel
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By Indication
- 7.4.3 By Distribution Channel
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By Indication
- 7.5.3 By Distribution Channel
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By Indication
- 7.6.3 By Distribution Channel
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL COPD AND ASTHMA DEVICES INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 GF Health Products Inc
- 9.2.2 Koninklijke Philips N.V. (Philips)
- 9.2.3 3M Company
- 9.2.4 Boehringer Ingelheim International GmbH
- 9.2.5 PARI Medical Holding GMBH
- 9.2.6 AstraZeneca PLC
- 9.2.7 Smith's Group Plc
- 9.2.8 Aerogen Inc
- 9.2.9 Baxter International Inc
- 9.2.10 GlaxoSmithKline Plc
- 9.2.11 Novartis AG
